Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. Net Income 2022–2025
Taysha Gene Therapies Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Taysha Gene Therapies Inc. net income for the quarter ending March 31, 2026 was -42.4 M, a 96.99% increase year-over-year.
- Taysha Gene Therapies Inc. net income for the twelve months ending March 31, 2026 was -123.6 M, a 34.14% decrease year-over-year.
- Taysha Gene Therapies Inc. annual net income for 2025 was -109.0 M, a 22.06% increase from 2024.
- Taysha Gene Therapies Inc. annual net income for 2024 was -89.3 M, a 19.96% decrease from 2023.
- Taysha Gene Therapies Inc. annual net income for 2023 was -111.6 M, a 32.80% decrease from 2022.
- Taysha Gene Therapies Inc. annual net income for 2022 was -166.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Taysha Gene Therapies Inc. Net Income — FAQ
Taysha Gene Therapies Inc. (TSHA) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Taysha Gene Therapies Inc.'s net income?
Taysha Gene Therapies Inc. (TSHA) reported net income of -$109M for fiscal 2025.
Where can I see TSHA's net income history?
The chart and table above show Taysha Gene Therapies Inc.'s net income by year and by quarter, including the growth rate.